Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch
  

Dicerna Pharmaceuticals Inc patents

Recent patent applications related to Dicerna Pharmaceuticals Inc. Dicerna Pharmaceuticals Inc is listed as an Agent/Assignee. Note: Dicerna Pharmaceuticals Inc may have other listings under different names/spellings. We're not affiliated with Dicerna Pharmaceuticals Inc, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "D" | Dicerna Pharmaceuticals Inc-related inventors




Date Dicerna Pharmaceuticals Inc patents (updated weekly) - BOOKMARK this page
05/18/17Amine cationic lipids and uses thereof
05/11/17Methods and compositions for the specific inhibition of alpha-1 antitrypsin by double-standed rna
04/13/17Acetyl-coa carboxylases
10/20/16Methods and compositions for the specific inhibition of transthyretin (ttr) by double-stranded rna
09/29/16Methods and compositions for the specific inhibition of myc by double-stranded rna
08/18/16Methods and compositions for the specific inhibition of complement component 5(c5) by double-stranded rna
06/30/16Methods and compositions for the specific inhibition of beta-catenin by double-stranded rna
06/23/16Methods and compositions for the specific inhibition of hif-1a by double-stranded rna
03/24/16Phase changing formulations of nucleic acid payloads
02/25/16Methods and compositions for the specific inhibition of beta-catenin by double-stranded rna
12/31/15Process for formulating an anionic agent
11/05/15Methods and compositions for the specific inhibition of ckap5 by double-stranded rna
08/27/15Methods and compositions for the specific inhibition of myc by double-stranded rna
07/16/15Methods and compositions for the specific inhibition of androgen receptor by double-stranded rna
07/02/15Methods and compositions for the specific inhibition of glycolate oxidase (hao1) by double-stranded rna
03/05/15Methods and compositions for the specific inhibition of mcl1 by double-stranded rna
02/26/15Methods and compositions for the specific inhibition of kras by asymmetric double-stranded rna
02/05/15Extended dicer substrate agents and methods for the specific inhibition of gene expression
02/05/15Extended dicer substrate agents and methods for the specific inhibition of gene expression
01/08/15Methods and compositions for the specific inhibition of alpha-1 antitrypsin by double-stranded rna
12/18/14Amine cationic lipids and uses thereof
10/23/14Methods and compositions for the specific inhibition of met by double stranded rna
08/07/14Extended dicer substrate agents and methods for the specific inhibition of gene expression
06/26/14Phase changing formulations of nucleic acid payloads
06/05/14Methods and compositions for the specific inhibitions of egfr by double-stranded rna
04/17/14Methods and compositions for the specific inhibition of myc by double-stranded rna
02/13/14Rnai pharmaceutical composition for suppressing expression of kras gene
08/29/13Lipid delivery formulations
05/23/13Methods and compositions for the specific inhibition of androgen receptor by double-stranded rna
05/16/13Methods and compositions for the specific inhibition of kras by asymmetric double-stranded rna
05/02/13Methods and compositions for the specific inhibition of beta-catenin by double-stranded rna
04/18/13Single stranded extended dicer substrate agents and methods for the specific inhibition of gene expression
02/14/13Compositions and methods for the specific inhibition of gene expression by dsrna containing modified nucleotides
10/18/12Multiplex dicer substrate rna interference molecules having joining sequences
04/19/12Compositions and methods for the specific inhibition of gene expression by nucleic acid containing a dicer substrate and a receptor binding region
05/12/11Peptide dicer substrate agents and methods for their specific inhibition of gene expression
03/10/11Peptide dicer substrate agents and methods for their specific inhibition of gene expression
01/27/11Methods and compositions for the specific inhibition of kras by asymmetric double-stranded rna
01/06/11Single stranded extended dicer substrate agents and methods for the specific inhibition of gene expression
07/22/10Extended dicer substrate agents and methods for the specific inhibition of gene expression
07/08/10Extended dicer substrate agents and methods for the specific inhibition of gene expression
07/08/10Extended dicer substrate agents and methods for the specific inhibition of gene expression







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Dicerna Pharmaceuticals Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Dicerna Pharmaceuticals Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';